1. Home
  2. KRO vs MRVI Comparison

KRO vs MRVI Comparison

Compare KRO & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$7.81

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$7.30

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRO
MRVI
Founded
1916
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
KRO
MRVI
Price
$7.81
$7.30
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$8.50
$8.50
AVG Volume (30 Days)
315.0K
★ 2.3M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 2.62%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ 0.09
N/A
Revenue
★ $1,859,400,000.00
$185,743,000.00
Revenue This Year
$11.05
$14.01
Revenue Next Year
$1.77
$6.20
P/E Ratio
$85.22
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.08
$2.55
52 Week High
$9.17
$9.42

Technical Indicators

Market Signals
Indicator
KRO
MRVI
Relative Strength Index (RSI) 50.98 50.65
Support Level $7.43 $6.41
Resistance Level $7.89 $7.60
Average True Range (ATR) 0.25 0.51
MACD 0.02 -0.01
Stochastic Oscillator 69.23 39.53

Price Performance

Historical Comparison
KRO
MRVI

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: